BMCS Stock UPDATES Biotech Medics Ne (BMCS) 0.0011 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biotech Medics Ne (BMCS) 0.0011 $BMCS

BioTech Medics, Inc. Signs $5 Million Cross-Marketing Licensing Agreement With LifeBionix, Inc.
Marketwire - Mon Jul 01, 8:45AM CDT
BioTech Medics, Inc., (PINKSHEETS: BMCS) announced that it has signed a $5 million U.S. cross-marketing licensing non-exclusive contract for its patented SHBAN Alcohol Free Persistent Hand & Body Sanitizer with LifeBionix, Inc. The agreement includes cash and ongoing royalties payable to BioTech over a five year term anticipated to start third quarter 2013 without dilution of BioTech stock.

BioTech Medics Announces Walk-In Laser Center Kiosks Concept
Marketwire - Mon Jun 24, 9:01AM CDT
BioTech Medics, Inc., (PINKSHEETS: BMCS) announces it is planning BioTech Laser Center Walk-In Kiosks that can be located in malls and convention centers throughout the USA. BioTech Medic has five existing laser centers in four states offering high powered deep penetrating Class IIIB and Class IV FDA cleared laser treatment for muscle, joint, nerve and arthritic pain.

Flu Season Rages: SHBAN Hand Sanitizer Is Superior to Most Alcohol Gels
Marketwire - Tue Jan 29, 7:01AM CST
BioTech Medics, Inc., (PINKSHEETS: BMCS) distributors of SHBAN Alcohol Free Persistent Hand Sanitizer announces tips to help individuals combat the massive influenza outbreak. The Center for Disease Control (CDC) identified this flu season worse than normal. A new strain of stomach bug sweeping the globe is the Sydney norovirus.

As The Flu Season Rages SHBAN Persistent Hand Sanitizer Is Superior to Most Alcohol Gels
ACCESSWIRE-TNW - Mon Jan 28, 6:58AM CST
BioTech Medics, Inc., (PINKSHEETS: BMCS) distributors of SHBAN Alcohol Free Persistent Hand Sanitizer announces tips to help individuals to combat the massive 2013 influenza outbreak. The Center for Disease Control has identified the 2013 flu season as much worse than normal specifically for elderly people. 48 States have reported significant outbreaks. According to medical experts this years Flu Shots are only 62% effective. A new strain of stomach bug sweeping the globe is taking over in the U.S. Since September, more than 140 outbreaks in the U.S. according to the CDC have been caused by the new Sydney strain of norovirus. Flu shots are not effective against the Sydney norovirus strain.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading